Olive Leaf Extracts in the Control of Diabet
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.
Also called NCT05605704
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT05605704
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Tunisia
- Registry status
- Recruiting
Technical summary
Registry record NCT05605704. Randomized; single masking; primary purpose prevention. Start 2023-01-01 (actual); primary completion 2025-09-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Olive Leaf Extracts in the Control of Diabet
- Acronym
- Dia-Athr
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Atherolive
- Intervention (Drug)
- Placebo Atherolive
- Lead sponsor
- University of Monastir
Record details
- Record id
cardio:ct-nct05605704- Content hash
1cd0d1fc3efec0b64167a782ed7dfba1d0ab1010fada159fa1914b2890177fb3